Teriparatide
Recombinant PTH(1-34) fragment sold as Forteo. Stimulates osteoblast-driven bone formation; the original approved anabolic agent for severe osteoporosis requiring more than antiresorptives.
0 anonymous reports
Also known as:
forteopth 1-34recombinant pth
community guides:
No reports found.
Community Q&A
- What does teriparatide do for bone?
- Community accounts describe teriparatide as the established anabolic bone treatment — the one peptide-class compound in the bone space with decades of clinical data behind it. Accounts from osteoporosis patients describe significant bone density gains over 18–24 month courses that exceeded what bisphosphonates or other antiresorptives achieved. The daily injection and 2-year treatment limit (after which a different agent must continue) appear consistently in confessions as practical constraints.
- Is teriparatide used for bodybuilding or healing?
- Off-label teriparatide accounts exist in the community — describing use for accelerating fracture healing or improving bone density in at-risk athletes. The rationale: PTH receptor activation drives osteoblast activity, which theoretically accelerates fracture callus formation. These accounts are less common than the medical osteoporosis use case. The cost and injection requirement of teriparatide make it a specialist choice rather than a casual community compound.